Bibliografia Sugerida

Akesson A, Wollheim FA. Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison

between the CREST syndrome and diffuse scleroderma. Br J Rheumatol. 1989; 28:281.

Aletaha D, Neogi T, Silman Aj et al. Rheumatoid arthrits classi cation criteria: an American College of

Rheumatology/European league Against Rheumatism collaborative initiative. Arthrits Rheum. 2010;

62:2569.

Black CM. Scleroderma: clinical aspects. J Intern Med. 1993; 234:115.

Braun J, Golder W, Bollow M et al. Imaging and scoring in ankylosing spondilitis. Clin Exp Rheumatol. 2002; 20(6

Suppl 28): S178-84.

Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative

Aging Study. Am J Med. 1987; 82:421.

Carvalho MAP, Lanna CCD, Bertolo MB. Reumatologia. Diagnóstico e tratamento. 3. ed. 2008; 309-28.

Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011; 377(9783): 2127-37.

Gonçalves CR, Saad CGS. Espondilite Anquilosante: Quadro clínico e diagnóstico. In: Sampaio-Barros PD.

Fundamentos das Espondiloartrites. Souders Elsevier, 2012. p. 23-33.

Hall AP, Barry PE, Dawber TR, McNamara PM. Epidemiology of gout and hyperuricemia. A long-term population

study. Am J Med. 1967; 42:27.

Harris RE, Clauw DJ, Scott DJ et al. Decreased central mu-opioid receptors avaibility in bromyalgia. J Neurosci.

2007; 27:10000-6.

Hellmann DB, Imboden JB, Stone J. Current: rheumatology, diagnosis & treatment. Mcgraw-Hill Interamericana;

2008. p. 138-45.

Hellmann DB, Imboden JB, Stone J. Current: rheumatology, diagnosis & treatment. Mcgraw-Hill Interamericana;

2012. p. 139-55.

Hochberg MC, Silman AJ, Smolen JS, Weinbatt ME, Weisman MH. Rheumatology. 5. ed. Philadelphia: Mosby

Elsevier; 2010.

Imboden J, Hellmann D, Stone J. Current Diagnosis & Treatment Rheumatology. 2 ed. New York: McGraw-Hill;

1997.

Kahl L, Henderson KE, De Fer TM. Rheumatology the eashington manual subspecialty consult series. Second

Edition. 2012.

Klippel JH, Stone JH, Crofford LJ, White PH. Primer on the rheumatic diseases. Thirteenth Edition. Spinger, 2008.

Korn JH, Mayes M, Matucci Cerinic M et al. Digital ulcers in systemic sclerosis: prevention by treatment with

bosentan, an oral endothelin receptor antagonist. Arthritis Rheum. 2004; 50:3985.

LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classi cation, subsets and pathogenesis.

J Rheumatol. 1988; 15:202.

MacGregor AI, Silman AJ. Rheumatoid arthritis and orther synovial disorders. Classi cation and Epidemiology. In:

Hochberg MC, Slman AJ, Smolen JF, Weinblat ME, Weisman MH. Rheumatology. 4. Ed. New York, NY:

Mosby, 2008; 755-61.

Maksymowych WP. MRI in ankylosing spondilitis. Curr Opin Rheumatol. 2009; 21(4):313-7.

Marie I, Dominique S, Levesque H et al. Esophageal involvement and pulmonary manifestations in systemic

sclerosis. Arthritis Rheum. 2001; 45:346.

Moreira C, Pinheiro GRC, Marques Neto JF. Reumatologia essencial. Rio de Janeiro: Guanabara Koogan; 2009.

Mota LMH et al. Consenso da Sociedade Brasileira de Reumatologia 2011 para o diagnóstico e avaliação inicial da

artrite reumatoide. Rev Bras Reumatol. São Paulo, 2011 june; 51(3). Dis ponível em:

<http://www.scielo.br/scielo.php?script=sci_arttext &pid=S0482-

50042011000300002&lng=en&nrm=iso>. Acesso em: 10 de abril de 2013.

Sall K, Stevenson OD, Mundorf S et al. Two multicenter, randomized studies of the efficacy and safety of

ciclosporine ophtalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 study Group.

Ophthalmology. 2000; 107:631-9.

Sampaio-Barros PD, Azevedo VF, Bon glioli R et al. Consenso brasileiro de espondiloartropatias: espondilite

anquilosante e artrite psoriásica. Diagnóstico e tratamento. Primeira Revisão. Rev Bras Reumatol. 2007;

47:234-51.

Sampaio-Barros PD, Bertolo MB, Kraemer MH, Neto JF, Samara AM. Primary ankylosing spondylitis: patterns of

disease in a Brazilian population of 147 patients. J Rheumatol. 2001 Mar; 28(3):560-5.

Sato EI. Guias de medicina ambulatorial e hospitalar da UNIFESPEPM. 2 ed. São Paulo: Manole; 2010.

Shiboski SC, Criswell LA, Baer AN et al. American College of Rheumatology Classi cation Criteria for Sjogren’s

Syndrome: A Data-Driven, Expert Consensus Approach in the Sjogren’s International Collaborative Clinical

Alliance Cohort. Arthritis Care & Research. 2012; 64:475-87.

Spoorenberg A, van der Heijde D, de Klerk E et al. Relative value of erithrocyte sedmentation rate and C-reative

protein in assessment of disease activity in ankylosing spondilitis. J Rheumatol. 1999; 26:980-4.

Sutaria S, Katbamna R, Underwood M. Effectiveness of interventions for the treatment of acute and prevention of

recurrent gout – a systematic review. Rheumatology (Oxford) 2006; 45:1422.

van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondilitis. A proposal

for modi cation of the New York criteria. Arthitis Rheum. 1984; 27(4):361-8.

Wallace SL, Singer JZ. Therapy in gout. Rheum Dis Clin North Am. 1988; 14:441.

Wolf F, Smythe HÁ, Yunus MB, Bennet RM. The American College of Rheumatology 1990 Criteria. For the

classi cation of bromyalgia. Arthritis & Rheum. 1990; 33:160-72.

Zalokar J, Lellouch J, Claude JR, Kuntz D. Epidemiology of serum uric acid and gout in Frenchmen. J Chronic Dis.

1974; 27:59.

Zochling J, Heije van der D et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Ann Rheum Dis. 2006; 65:442-52.

OceanofPDF.com